openPR Logo
Press release

Ipsen to explore oral peptides innovations, advances and delivery

12-06-2017 11:53 AM CET | Health & Medicine

Press release from: SMi Group

Ipsen to explore oral peptides innovations, advances

SMi Group have announced that Joël Richard, Senior Vice President, Peptides Development at Ipsen, will be joining the speaker line-up for the 15th annual Controlled Release Delivery conference in London.

Speaking on Day 1 of the event, Joël will provide an opening address exploring the advances in non-invasive routes of administration of peptides with a focus on successful oral technologies progressing in the clinic. Key highlights of his presentation will include

• Peptides delivery landscape and importance of non-invasive routes of administration
• Oral peptides delivery - strong expectations and opportunities from the market
• Key oral peptides formulation excipients
• Oral peptides technologies progressed in the clinic
• Lessons learnt from clinical studies
• Future challenges & prospects

The presentation comes at a relevant time, with peptide therapeutics becoming more prevalent within the market due to their high potency and effectivity, self-emulsifying drug delivery systems and safety. With the rising demand for effective drugs and technology, it is an exciting time for peptide development and there is a need to understand and acknowledge the challenges for optimal commercialisation and prominence.

More details about Joël’s presentation, as well as the full speaker line-up for the conference can be found on www.controlledreleasedelivery.com/openPR.

Now running for 15 years, Controlled Release Delivery 2018 aims to explore and to understand innovations in oral-lipid based and abuse deterrent formulations, nanoparticles and nanotechnologies, taste-masking and controlled release approaches, 3D printed dosage forms and functional film coats.

For those interested to attend, registration is now live on the event website and there is currently an Early Bird Discount of £200 which expires on 15 December 2017.

15th Controlled Release Delivery Conference
21-22 March 2018
Copthorne Tara Hotel, London, UK

--- END ---
For delegate registration enquiries, contact Kieran Ronaldson on kronaldson@smi-online.co.uk. For media enquiries, contact Honey de Gracia at hdegracia@smi-online.co.uk.

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk.

1 Westminster Bridge Road, London, SE1 7XW

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ipsen to explore oral peptides innovations, advances and delivery here

News-ID: 847726 • Views:

More Releases from SMi Group

Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug Discovery Conference
Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug D …
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3rd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK. The conference will have a focus on case studies from leading pharma and biotech firms, as well as a exploring the latest innovations in machine learning for enhancing discovery pipelines. Darren Green, Director of Computational Chemistry at GSK will be chairing at
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coast 2022
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coa …
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety. SMi Group is delighted to announce the 5th Annual Pharmaceutical Microbiology East Coast Conference, taking place on the 27th and 28th April 2022 in Boston, USA. The 2022 Conference theme is
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Conference with Online Access Only
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Confer …
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022. SMi’s 10th Annual Pharmaceutical Microbiology UK Conference will no longer take place in London, UK. Instead, the conference is taking place on 17 and 18 January 2022 and will open its doors to a global audience delivering
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th Annual 3D Cell Culture Conference
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th A …
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022. Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and Stefan Przyborski, Professor in Cell Technology, Durham University invite industry professionals by releasing invite letter to join SMi’s 5th Annual 3D Cell Culture Conference 2022. This event will convene on February 9th – 10th 2022,

All 5 Releases


More Releases for Ipsen

Botox Injection Market SWOT Analysis with Allergan, Ipsen, Medytox
Latest Study on Industrial Growth of Global Botox Injection Market 2023-2029. A detailed study accumulated to offer the Latest insights about acute features of the Botox Injection market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends
(2023-2031) Acromegaly Market | Novartis AG, Ipsen Pharma
[100 pages] Report "Acromegaly Market" detailed analysis of a business is mainly segmented by Application, by Type, Region (North America, Europe, Asia-Pacific, South America, and Middle East & Africa), manufacture and Forecast to 2031. "Final Report will add the analysis of the impact of COVID-19 on this industry." Global "Acromegaly Market" report analyses the best market prospects and lists the characteristics that are and will continue to propel the development of the
Acromegaly Therapeutics Market Is Thriving Worldwide | Novartis, IPSEN, Pfizer
DataIntelo report titled Global Acromegaly Therapeutics Market provides detailed information and overview about the key influential factors required to make well informed business decision. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the
Acromegaly Treatment Market 2020 Strategic Assessments - Novartis, IPSEN, Pfizer
The global Acromegaly Treatment Market Research Report 2020-2026 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report. (Special
Global Hormone Replacement Therapy Market 2019 - Ipsen, Merck, Mylan Laboratorie …
Hormone replacement therapy refers to the treatment of the patients with growth hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low. Get Free Sample Copy of Report Here: https://bit.ly/2DarxJV Scope of the Report: This report studies the Hormone Replacement Therapy market status and outlook of Global and major regions, from angles of players, countries, product
Global Triptorelin Acetate Market 2018-2025 Ipsen, Ferring, Chengdu Tiantaishan, …
Market study on Global Triptorelin Acetate Market 2018 Research Report presents a professional and complete analysis of Global Triptorelin Acetate Market on the current market situation. Report provides a general overview of the Triptorelin Acetate industry 2018 including definitions, classifications, Triptorelin Acetate market analysis, a wide range of applications and Triptorelin Acetate industry chain structure. The 2018's report on Triptorelin Acetate industry offers the global Triptorelin Acetate development history,